Savara (SVRA) Change in Account Payables (2016 - 2017)
Savara (SVRA) reported Change in Account Payables of -$127000.0 for Q1 2017, up 83.63% year-over-year from -$69159.3 in Q1 2016, and up 83.63% quarter-over-quarter from -$776000.0 in Q1 2016.
Savara (SVRA) Change in Account Payables (2016 - 2017) Analysis & Trends
Savara (SVRA) has 2 years of Change in Account Payables data on file, last reported at -$127000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -127,000.00 |
| Mar 31, 2017 | -127,000.00 |
| Mar 31, 2016 | -776,000.00 |
| Mar 31, 2016 | -776,000.00 |